2019
A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database Study
Liu H, Gu Z, Qiu B, Detterbeck FC, Roden AC, Ruffini E, Okumura M, Girard N, Xiang Y, Liu Y, Du Z, Hao Y, Fu J, Zhang P, Pang L, Chen K, Wang Y, Yu Z, Mao T, Fang W, Group A. A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database Study. Journal Of Thoracic Oncology 2019, 15: 448-456. PMID: 31726106, DOI: 10.1016/j.jtho.2019.10.018.Peer-Reviewed Original ResearchConceptsHigh-risk patientsAdjuvant therapyPostoperative yearThymic carcinomaComplete resectionPostoperative managementNeuroendocrine tumorsBootstrap-corrected C-indexChinese AlliancePostoperative adjuvant therapyIndependent predictive factorsLow-risk patientsMultivariate Cox regressionOverall survival rateAppropriate postoperative managementThymic epithelial tumorsHigh-risk groupLow-risk groupIIIA tumorsLocoregional recurrenceDisease recurrenceB3 thymomaHistologic typeNomogram modelT stage
2014
Hospital Readmission After Pulmonary Lobectomy Is Not Affected by Surgical Approach
Assi R, Wong DJ, Boffa DJ, Detterbeck FC, Wang Z, Chupp GL, Kim AW. Hospital Readmission After Pulmonary Lobectomy Is Not Affected by Surgical Approach. The Annals Of Thoracic Surgery 2014, 99: 393-398. PMID: 25497070, DOI: 10.1016/j.athoracsur.2014.10.014.Peer-Reviewed Original ResearchConceptsCharlson Comorbidity IndexDays of dischargePredictors of readmissionIntensive care unitUnplanned returnPulmonary lobectomyComorbidity indexHospital readmissionSurgical approachCare unitHigher Charlson comorbidity indexMedian hospital lengthMultivariate logistic regression methodThoracic surgery serviceHigh-risk patientsPostoperative mortalityPostoperative transferHospital lengthPostoperative complicationsExpiratory volumeSurgery serviceOpen thoracotomyPathologic diagnosisUnplanned transfersMedical records
2012
American College of Chest Physicians and Society of Thoracic Surgeons Consensus Statement for Evaluation and Management for High-Risk Patients With Stage I Non-small Cell Lung Cancer
Donington J, Ferguson M, Mazzone P, Handy J, Schuchert M, Fernando H, Loo B, Lanuti M, de Hoyos A, Detterbeck F, Pennathur A, Howington J, Landreneau R, Silvestri G, Surgeons F. American College of Chest Physicians and Society of Thoracic Surgeons Consensus Statement for Evaluation and Management for High-Risk Patients With Stage I Non-small Cell Lung Cancer. CHEST Journal 2012, 142: 1620-1635. PMID: 23208335, DOI: 10.1378/chest.12-0790.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerStage I non-small cell lung cancerHigh-risk patientsCell lung cancerChest PhysiciansTreatment optionsLung cancerAmerican CollegeStereotactic body radiation therapySevere medical comorbiditiesThoracic Oncology NetworkAlternative treatment optionMore indolent tumorsBody radiation therapyRisk-benefit decisionsInterventional riskMedical comorbiditiesNonoperative therapyRespiratory failureInvolved lobeMediastinal lymphProcedural morbidityRegional recurrenceSublobar resectionRadiographic staging